SCHEMBL30769217

SCHEMBL30769217

COC(=O)C(C1CCCCC1)C(C)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ALOX5 P09917 1/20 0.47
▸ PTGES O14684 1/20 0.46
▸ PDE4A P27815 1/20 0.46
▸ PDE4B Q07343 1/20 0.46
▸ PDE4C Q08493 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ FFAR1 O14842 1/20 0.45
▸ LTA4H P09960 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ BCHE P06276 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ ACACA Q13085 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ CHRM3 P20309 3/20 0.43
▸ EPOR P19235 1/20 0.43
▸ ALOX5AP P20292 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31682322 0.80 FFAR1 (0.62) FFAR1
SCHEMBL15973261 0.80 FFAR1 (0.62) FFAR1
SCHEMBL15973260 0.80 FFAR1 (0.62) FFAR1
SCHEMBL19696089 0.80 FFAR1 (0.62) FFAR1
SCHEMBL19175806 0.80 FFAR1 (0.62) FFAR1
SCHEMBL30769418 0.79 PTGES (0.47) KMT2ASMN1; SMN2PTGESFFAR1LTA4H
SCHEMBL2853880 0.78 ALOX5 (0.63) KMT2ASMN1; SMN2ALOX5PTGESLTA4H
SCHEMBL2847366 0.76 KMT2A (0.51) KMT2ASMN1; SMN2ALOX5PTGESFFAR1
SCHEMBL9432429 0.76 KMT2A (0.59) KMT2ASMN1; SMN2ALOX5LTA4HMEN1
SCHEMBL9019941 0.76 KMT2A (0.59) KMT2ASMN1; SMN2ALOX5LTA4HMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543871-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-04-30 — — EP disclosed
WO-2024006781-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-01-04 — — WO disclosed
Send feedback